Decreased plasma antioxidants in patients with Alzheimer's disease

International Journal of Geriatric Psychiatry

Volumn 21, Issue 4, 2006, Pages 344-348

  Kim, Tae Suk ^a   Pae, Chi Un ^a   Yoon, Su Jung ^b   Jang, Woo Young ^a   Lee, Nam Jin ^c   Kim, Jung Jin ^a   Lee, Soo Jung ^a   Lee, Chul ^a   Paik, In Ho ^a   Lee, Chang Uk ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Department of Psychiatry   (South Korea)

Author keywords

Alzheimer's disease; Antioxidants; Cognitive function

Indexed keywords

ALBUMIN; ANTIOXIDANT; BILIRUBIN; URIC ACID;

AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ALZHEIMER DISEASE; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD LEVEL; BODY MASS; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; OXIDATIVE STRESS; PATHOGENESIS; SEX DIFFERENCE; URIC ACID BLOOD LEVEL;

AGED; ALZHEIMER DISEASE; BILIRUBIN; BIOLOGICAL MARKERS; COGNITION DISORDERS; FEMALE; HUMANS; MALE; SERUM ALBUMIN; URIC ACID;

EID: 33646203803     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1469     Document Type: Article

References (36)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorder, 4th edn. American Psychiatric Association: Washington, DC.
2. Anneren G, Gardner A, Lundin T. 1986. Increased glutathione peroxidase activity in erythrocytes in patients with Alzheimer's disease/senile dementia of Alzheimer's type. Acta Neurol Scand 73:586-589.
3. Becker BE 1993. Towards the physiological function of uric acid. Free Radic Biol Med 14: 615-631.
4. Berr C, Balansard B, Arnaud J, Roussel AM, Alperovitch A. 2000. Cognitive decline is associated with systemic oxidative stress: the EVA study. Etude du Vieillissement Arteriel. J Am Geriatr Soc 48: 1285-1291.
5. Butterfield DA, Koppal T, Subramaniam R, Yatin S. 1999. Vitamin E as an antioxidant/free radical scavenger against amyloid beta-peptide-induced oxidative stress in neocortical synaptosomal membranes and hippocampal neurons in culture: insights into Alzheimer's disease. Rev Neurosci 10: 141-149.
6. Ceballos-Picot I, Merad-Boudia M, Nicole A, et al. 1996. Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type-place of the extracellular glutathione peroxidase. Free Radic Biol Med 20: 579-587.
7. Coyle JT, Puttfarcken P. 1993. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689-695.
8. Doumas BT, Watson WA, Biggs HG. 1971. Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 31: 87-96.
9. Droge W. 2003. Oxidative stress and aging. Adv Exp Med Biol 543: 191-200.
10. Ewing JF, Haber Sri, Maines MD. 1992. Normal and heat-induced pattems of expression of heme oxygenase-1 (HSP32) in rat brain: hyperthermia causes rapid induction of mRNA and protein. J Neurochem 58: 1140-1149.
11. Gochman N, Schmitz IM. 1971. Automated determination of uric acid, with use of a uricase-peroxidase system. Clin Chem 17: 1154-1159.
12. Kjellin KG. 1971. Bilirubin compounds in the CSF. J Neurol Sci 13:161-173.
13. Markesbury W, Ehmonn A. 1993. Brain trace elements in Alzheimer disease. In Alzheimer Disease, Terry R, Katzman R, Bick K (eds). Raven Press: New York.
14. Markesbery WR, Carney JM. 1999. Oxidative alterantions in Alzheimer's disease. Brain Pathol 9: 133-146.
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
16. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. 1993. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 84: 407-412.
17. Papas AM. 1999. Diet and antioxidant status. Food Chem Toxicol 37: 999-1007.
18. Park JH, Kwon YC. 1990. Modification of the Mini Mental State Examination for use in the elderly in a non-western society. 1. Development of Korean version Mini Mental State Examination. Int J Geriatr Psychiatry 5: 381-387.
19. Pearlman FC, Lee RT. 1974. Detection and measurement of total bilirubin in serum, with use of surfactants as solubilizing agents. Clin Chem 20: 447-453.
20. Poon HF, Calabrese V, Scapagnini G, Butterfield DA. 2004. Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress. J Gerontol A Biol Sci Med Sci 59: 478-493.
21. Reddy RD, Yao JK. 1996. Free radical pathology in schizophrenia: a review. Prostaglandins Leukot Essent Fatty Acids 55: 33-43.
22. Reiter RJ. 1995. Oxidative process and antioxidant defense mechanisms in the aging brain. FASEB J 9: 526-533.
23. Rodriguez-Garay EA, Scremin OU. 1971. Transfer of bilirubun-14C between blood, cerebrospinal fluid, and brain tissue. Am J Physiol 221: 1264-1270.
24. Sano M, Ernesto C, Thomas RG, et al. 1997. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 336: 1216-1222.
25. Singh S, Mulley GP, Losowsky MS. 1988. Carotenaemia in Alzheimer's disease. Br Med J 297: 458-459.
26. Soriani M, Pietraforte D, Minetti M. 1994. Antioxidant potential of anaerobic human plasma: role of serum albumin and thiols as scavengers of carbon radicals. Arch Biochem Biophys 312: 180-188.
27. Stocker R, Ames BN. 1987. Potential role of conjugated bilirubin and copper in the metabolism of lipid peroxidase in bile. Proc Nat Acad Sci USA 84: 8130-8134.
28. Stocker R, Yamamoto Y, McDonagh AF, Glazer An, Ames BN. 1987. Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046.
29. Subbarao KV, Richardson JS, Ang LC. 1990. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J Neurochem 55: 342-345.
30. Takahashi M, Sugiyama K, Shumiya S, Nagase S. 1984. Penetration of bilirubin into the brain in albumin-deficient and jaundiced rats (AJR) and Nagase analburninemic rats (NAR). J Biochem 96: 1705-1712.
31. Wayner DD, Burton GW, Ingold KU, Barclay LR, Locke SJ. 1987. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophys Acta 924: 408-419.
32. Wu TW, Carey D, Wu J, Sugiyarna H. 1991. The cytoprotective effects of bilirubin and biliverdin on rat hepatocyLes and human erythrocytes and the impact of aibumin. Biochem Cell Biol 69: 828-834.
33. Yao, JK, Reddy R, van Kammen DP. 2000. Abnormal age-related changes of plasma antioxidant proteins in schizophrenia. Psychiatry Res 97: 137-151.
34. Zaman Z, Roche S, Fielden P, Frost PG, Niriella DC, Cayley AC. 1992. Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease. Age Ageing 21: 91-94.
35. Zemlan FP, Thienhaus OJ, Bosmann HB. 1989. Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation. Brain Res 476: 160-162.
36. Zhu X, Raina AK, Peffy G, Smith MA. 2004. Alzheimer's disease: the two-hit hypothesis. Lancer Neurol 3: 219-226.